CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP
· Real-Time Price · USD
41.66
0.30 (0.73%)
At close: Jun 16, 2025, 3:59 PM
41.30
-0.86%
After-hours: Jun 16, 2025, 07:58 PM EDT
0.73% (1D)
| Bid | 41.1 |
| Market Cap | 3.6B |
| Revenue (ttm) | 36.98M |
| Net Income (ttm) | -385.66M |
| EPS (ttm) | -4.49 |
| PE Ratio (ttm) | -9.28 |
| Forward PE | -9.25 |
| Analyst | Buy |
| Ask | 42 |
| Volume | 1,489,400 |
| Avg. Volume (20D) | 2,159,174 |
| Open | 42.24 |
| Previous Close | 41.36 |
| Day's Range | 40.76 - 42.29 |
| 52-Week Range | 30.04 - 63.68 |
| Beta | 1.74 |
About CRSP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CRSP
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CRSP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-11.86%
Shares of vaccine and gene therapy stocks are trad...
Unlock content with
Pro Subscription
4 months ago
+14.33%
CRISPR Therapeutics shares are trading higher after Evercore ISI upgraded the stock from In-Line to Outperform and raised its price target from $60 to $99. Also, Morgan Stanley raised its price target from $30 to $32.
